SOL Capital Management CO Acquires 1,608 Shares of Humana Inc. (NYSE:HUM)

SOL Capital Management CO lifted its holdings in shares of Humana Inc. (NYSE:HUM - Free Report) by 13.1% during the first quarter, according to its most recent 13F filing with the Securities and Exchange Commission (SEC). The firm owned 13,908 shares of the insurance provider's stock after purchasing an additional 1,608 shares during the period. SOL Capital Management CO's holdings in Humana were worth $3,680,000 at the end of the most recent reporting period.

Other hedge funds also recently made changes to their positions in the company. LFA Lugano Financial Advisors SA raised its stake in Humana by 56.3% in the 4th quarter. LFA Lugano Financial Advisors SA now owns 125 shares of the insurance provider's stock valued at $32,000 after acquiring an additional 45 shares during the period. Riverview Trust Co bought a new stake in Humana in the 1st quarter valued at about $34,000. OFI Invest Asset Management bought a new stake in Humana in the 4th quarter valued at about $33,000. Garde Capital Inc. bought a new stake in Humana in the 1st quarter valued at about $36,000. Finally, Transce3nd LLC bought a new stake in Humana in the 4th quarter valued at about $38,000. 92.38% of the stock is currently owned by institutional investors.

Wall Street Analysts Forecast Growth

A number of research analysts have weighed in on the company. Barclays set a $268.00 target price on Humana and gave the company an "equal weight" rating in a report on Thursday, June 12th. Robert W. Baird lifted their target price on Humana from $270.00 to $300.00 and gave the company a "neutral" rating in a report on Tuesday, April 15th. Oppenheimer lifted their target price on Humana from $300.00 to $310.00 and gave the company an "outperform" rating in a report on Thursday, May 1st. Mizuho lifted their target price on Humana from $305.00 to $316.00 and gave the company an "outperform" rating in a report on Wednesday, April 9th. Finally, Guggenheim assumed coverage on Humana in a report on Wednesday, April 9th. They set a "buy" rating and a $326.00 target price for the company. Seventeen investment analysts have rated the stock with a hold rating and seven have assigned a buy rating to the company. According to MarketBeat, Humana currently has a consensus rating of "Hold" and an average price target of $280.76.

Humana Stock Down 0.0%

Shares of HUM opened at $238.69 on Thursday. The firm has a market cap of $28.81 billion, a P/E ratio of 16.88, a P/E/G ratio of 1.80 and a beta of 0.43. The stock has a 50 day simple moving average of $242.88 and a two-hundred day simple moving average of $260.05. The company has a debt-to-equity ratio of 0.71, a current ratio of 1.91 and a quick ratio of 1.91. Humana Inc. has a 1 year low of $212.45 and a 1 year high of $406.46.

Humana (NYSE:HUM - Get Free Report) last issued its earnings results on Wednesday, April 30th. The insurance provider reported $11.58 earnings per share (EPS) for the quarter, topping the consensus estimate of $10.07 by $1.51. The business had revenue of $32.11 billion during the quarter, compared to analyst estimates of $32 billion. Humana had a return on equity of 14.47% and a net margin of 1.42%. Humana's revenue for the quarter was up 8.4% on a year-over-year basis. During the same quarter in the prior year, the firm earned $7.23 earnings per share. On average, analysts forecast that Humana Inc. will post 16.47 earnings per share for the current fiscal year.

Humana Announces Dividend

The business also recently disclosed a quarterly dividend, which will be paid on Friday, July 25th. Stockholders of record on Friday, June 27th will be paid a dividend of $0.885 per share. This represents a $3.54 dividend on an annualized basis and a dividend yield of 1.48%. The ex-dividend date of this dividend is Friday, June 27th. Humana's dividend payout ratio (DPR) is presently 25.04%.

Humana Company Profile

Humana Inc, together with its subsidiaries, provides medical and specialty insurance products in the United States. It operates through two segments, Insurance and CenterWell. The company offers medical and supplemental benefit plans to individuals. It has a contract with Centers for Medicare and Medicaid Services to administer the Limited Income Newly Eligible Transition prescription drug plan program; and contracts with various states to provide Medicaid, dual eligible, and long-term support services benefits.

Want to see what other hedge funds are holding HUM? Visit HoldingsChannel.com to get the latest 13F filings and insider trades for Humana Inc. (NYSE:HUM - Free Report).

This instant news alert was generated by narrative science technology and financial data from MarketBeat in order to provide readers with the fastest and most accurate reporting. This story was reviewed by MarketBeat's editorial team prior to publication. Please send any questions or comments about this story to contact@marketbeat.com.